结果：大鼠肾脏病理符合2型糖尿病肾病的改变。
Results: Some pathological characteristics of diabetic nephropathy exist in type 2 diabetic rats.
目的探讨2型糖尿病肾病患者血清肌红蛋白水平。
Objective To explore the level of serum Mb in patients with type 2 diabetics.
目的探讨血管内皮生长因子与2型糖尿病肾病的关系。
Objective To explore the relationship between vascular endothelial growth factor and type 2 diabetic nephropathy .
结论：低分子肝素钙治疗2型糖尿病肾病是安全有效的。
Conclusion: low molecular weight heparin calcic is safer and more effective than the control group in the treatment of type 2 diabetic nephropathy.
目的：观察苯那普利治疗高血压合并2型糖尿病肾病的疗效。
Objective: To observe the efficacy of using benazepril to heal hypertension complicated with 2-type diabetic nephropathy.
目的：探讨2型糖尿病肾病患者血清瘦素水平及其影响因素。
Objective: to investigate the serum level of leptin in patients with type 2 diabetic nephropathy and its relation factors.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
目的：观察血清c反应蛋白在2型糖尿病肾病不同时期的变化。
AIM: To observe the changes of serum Creactive protein expression level in different periods of type 2 diabetic nephropathy.
目的：建立两种2型糖尿病肾病大鼠模型，比较两种模型的优缺点。
Objective: to establish two kinds of models of type 2 diabetic nephropathy in rats and to compare them.
结论：多时段血糖控制可延缓2型糖尿病肾病的发生并对肾病有改善作用。
Conclusion the more than 6 points blood glucose test and control will delay the onset and development of complication as diabetic nephropathy in type 2 diabetes.
预测因子与2型糖尿病肾病和高血压患者心血管事件的预测因子：蛋白尿因素。
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria.
结论：在1型糖尿病肾病患者中，血adma的水平对致命和非致命的心血管事件有预测作用。
Conclusions: Plasma ADMA levels predict fatal and non-fatal cardiovascular events in patients with type 1 nephropathy.
方法：采用病例对照研究的方法观察2型糖尿病、2型糖尿病肾病合并高血压和不合并高血压患者血脂水平的变化。
Method: Case control study was used to observe the changes of serum lipid levels in type 2 diabetes patients and type 2 diabetic nephropathy patients with hypertension or normotension.
目的研究血管紧张素转换酶抑制剂(acei)和血管紧张素受体拮抗剂(arb)对2型糖尿病肾病患者肾功能的保护作用。
Objective to investigate the protective effect of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) on renal function of type 2 diabetic nephropathy patients.
目的建立使用间接酶联免疫吸附法(ELISA)检测人血浆抗碳酸酐酶iv抗体的方法，阐明血浆抗碳酸酐酶iv抗体滴度与肾病综征合(ns)、慢性肾小球肾炎(CGN)和2 -型糖尿病肾病(2 - DN)三种肾脏病的联系。
Objective to develop a indirect ELISA method for the detection of plasma anti-CA iv antibody and to evaluate the relationship between anti-CA iv antibody with pathogenesis of ns, CGN and 2-dn.
研究结论：对1型糖尿病患者早期应用肾素血管紧张素抑制剂并不能缓解糖尿病肾病的进展但可以减缓视网膜病变。
Conclusions Early blockade of the renin-angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy.
目的观察低分子蛋白尿对2型糖尿病微量蛋白尿患者进展到临床糖尿病肾病的预后判断作用。
Objective To investigate the predictive value of urinary low molecular weight proteins for progression of diabetic nephropathy in type 2 diabetic patient with microalbuminuria.
目的观察低分子肝素联合缬沙坦对2型早期糖尿病肾病（DN）患者尿白蛋白排泄率（UAER）的影响。
Objective To investigate the impact of low molecular heparin(LMH)and valsartan on urine albumin excretion rate(UAER)in patients with early type-2 diabetic nephropathy(DN).
方法：112例2型糖尿病性肾病患者随机分为①对照组：仅用包括降糖疗法的一般糖尿病性肾病治疗方法；
Methods: 112 cases of type 2 diabetic nephropathy were divided into two groups, involved in a randomized control clinical trial.
良好的1年和5年移植器官生存率支持采用SPK治疗1型糖尿病相关的终末期肾病。
Excellent 1 - and 5-year organ survival rates favor the use of SPK in type 1 diabetics associated with end-stage renal disease.
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察缬沙坦对2型糖尿病早期肾病相关炎症因子的影响及对糖尿病肾病的保护作用。
Objective: to study the influence of valsartan to correlated inflammatory cytokine in early stage of type 2 diabetic nephropathy and the protection to diabetic nephropathy.
临床糖尿病肾病组的TC／CC基因型频率和-429C等位基因频率显著低于其它各组；
The frequencies of genotype TC/CC and -429C allele in group CDN were lower than other groups.
结论ICAM- 1 K469E多态性与2型糖尿病伴发肾病的发生有关，K等位基因可能是DN的易感基因。
Conclusions K469E polymorphism of ICAM-1 is associated with type 2 DN, and K allele may be susceptible to DN.
结论：AGT基因235T等位基因、糖尿病病程长、既往高血压史均可增加2型糖尿病患者合并肾病的危险；
Conclusion:Allele T of AGT gene M235T, the longer diabetes duration and history of hypertension were associated with higher risk of nephropathy in type 2 diabetic patients.
结论老年男性2型糖尿病患者的骨密度与多种因素有关，糖尿病肾病的进展是其重要的影响因素。
Conclusion BMD of elder male type 2 diabetic patients were affected by varied factors, especially by gradually deteriorating diabetic nephropathy.
结论老年男性2型糖尿病患者的骨密度与多种因素有关，糖尿病肾病的进展是其重要的影响因素。
Conclusion BMD of elder male type 2 diabetic patients were affected by varied factors, especially by gradually deteriorating diabetic nephropathy.
应用推荐